4 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow [18F] Flutemetamol: new trials by email Literature Review of [18F] Flutemetamol trials Research Report on [18F] Flutemetamol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of PET Amyloid Imaging in Japanese and Western Subjects [18F] Flutemetamol - Mild Cognitive Impairment, Alzheimer's Disease | Phase 2 | Completed | GE Healthcare | 70 | 2012-10-01 | 2017-06-05 |
| Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects [18F] Flutemetamol - Healthy | Phase 3 | Completed | GE Healthcare | 218 | 2010-12-01 | 2013-07-02 |
| Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels [18F] Flutemetamol - Brain Fibrillarab Levels | Phase 3 | Completed | GE Healthcare | 203 | 2010-05-01 | 2013-12-04 |
| PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus [18F] Flutemetamol - Normal Pressure Hydrocephalus | Phase 3 | Completed | GE Healthcare | 7 | 2009-12-01 | 2012-06-11 |
Alzheimer Disease (4) · Cognitive Dysfunction (1) · Hydrocephalus, Normal Pressure (1)
GE Healthcare (4)
United States (3)
Paul Sherwin, MD, PhD (2) · Kim A Mansfield, MS (1) · Levent Ture (1)
PMID 27955679, PMID 28181118, PMID 30123935, PMID 31727169, PMID 37777806, PMID 38048354